Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances
Israel-based Scopio Labs announced the FDA granted De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) software that provides AI-enabled decision support tools for bone marrow analysis. The FF-BMA application allows for bone marrow…
Continue Reading